VJHemOnc is committed to improving our service to you

ICML 2019 | PTCL arising as a PTLD: the efficacy of pralatrexate

VJHemOnc is committed to improving our service to you

Owen O'Connor

Owen O’Connor, MD, PhD, Columbia University Medical Center, New York, NY, discusses peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder (PTLD) and the efficacy of pralatrexate for the treatment of this condition. To read the specific case report mentioned please use this link: https://www.ncbi.nlm.nih.gov/pubmed/31184235

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter